Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK561679 in Women With Post-traumatic Stress Disorder
NCT01018992Phase 2Completed
- Sponsor
- Emory University
- Start
- Dec 2009
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of verucerfont in post-traumatic stress disorder (PTSD), sponsored by Emory University. Started Dec 2009; status: completed.
02
Drugs
verucerfont
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT01018992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01018992.